Clinical Trials Logo

Clinical Trial Summary

Colorectal carcinoma is one of the most aggressive malignant epithelial neoplasms affecting the gastrointestinal tract. The incidence of colorectal carcinoma is obviously increasing in developing countries, where the physical inactivity and the consumption of animal fat-rich food became more evident. Colorectal tumorigenesis is a multistep process which is initiated by adenoma and is terminated by carcinoma, the latter shows variable degrees of tumor differentiation and invasiveness. During the adenoma-carcinoma process; a series of genetic mutations occur. Detection of these genetic mutations will help in the development of novel therapeutic agents, which in turn will improve patients' outcomes. Cortactin (CTTN) is a Src kinase substrate, encoded by a gene located on chromosome 11. CTTN binds to and activates Arp 2/3 and stabilizes the dynamic actin assembly after its formation. So, it become clear that CTTN is involved in the formation of the leading-edges cellular protrusions.


Clinical Trial Description

Colorectal carcinoma is a highly lethal malignant epithelial tumor involving humans. The incidence of colorectal carcinoma is steadily increasing in developing countries, this could be assigned to low physical activity together with high consumption of animal fat-rich food. malignancy of the colon is a multistep process which is initiated by adenoma that proceeds to carcinoma, the latter includes a wide variety of tumor phenotypes. During the adenoma-carcinoma process; a series of genetic and epigenetic alterations occur. Detection of these genetic alterations is of great benefit in the future management of colorectal carcinomas. Cortactin (CTTN) is a Src kinase substrate, encoded by a gene located on chromosome 11. CTTN anchors the dynamic actin assembly . CTTN is implicated in the formation of the leading-edges cellular protrusions.the aim of this study is to evaluate expression of CTTN in 50 cases of colorectal adenocarcinomas and their adjacent normal colonic mucosae. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05225870
Study type Interventional
Source Sohag University
Contact
Status Completed
Phase N/A
Start date January 1, 2021
Completion date December 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT03179358 - Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC N/A
Recruiting NCT03976960 - Clinical and Biological Database in Colon Cancer and Colic Tumors N/A
Recruiting NCT06119425 - Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands N/A
Not yet recruiting NCT04079946 - The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment N/A
Recruiting NCT05177484 - Perioperative Iron for Colorectal Cancer (PICoC Study) Phase 3
Completed NCT03951792 - Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Recruiting NCT03722121 - Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Recruiting NCT04972994 - Laparoscopic Colectomies In Management of Colonic Cancers N/A
Recruiting NCT02542670 - Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. N/A
Completed NCT03688906 - AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Completed NCT04400552 - Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients N/A
Withdrawn NCT03185416 - Early Palliative Care Integration in Interventional Cancer Care N/A
Completed NCT01533090 - Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy N/A